Isolating pathogenic mechanisms embedded within the hippocampal circuit through regional vulnerability

Neuron

Volumn 84, Issue 1, 2014, Pages 32-39

  Small, Scott A ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; GLUTAMIC ACID; PROTEIN; RETINOBLASTOMA BINDING PROTEIN 4; RETROMER; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; AMINO ACID METABOLISM; AMNESIA; APOE4 GENE; BRAIN ATROPHY; BRAIN MAPPING; BRAIN REGION; COGNITIVE AGING; COGNITIVE DEFECT; DENTATE GYRUS; DISEASE COURSE; ENDOSOME; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; HUMAN; MOLECULAR PATHOLOGY; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; PROCESS OPTIMIZATION; REVIEW; SCHIZOPHRENIA; SORL1 GENE; ANIMAL; NERVE CELL NETWORK; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

ANIMALS; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; NERVE NET; NERVOUS SYSTEM DISEASES;

EID: 84908011629     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2014.08.030     Document Type: Review

References (83)

1. Adams D.H., Zhang L., Millen B.A., Kinon B.J., Gomez J.C. Pomaglumetad methionil (LY2140023 monohydrate) and aripiprazole in patients with schizophrenia: a phase 3, multicenter, double-blind comparison. Schizophr. Res. Treatment 2014, 2014:758212.
2. Adriano F., Caltagirone C., Spalletta G. Hippocampal volume reduction in first-episode and chronic schizophrenia: a review and meta-analysis. Neuroscientist 2012, 18:180-200.
3. Ando K., Brion J.P., Stygelbout V., Suain V., Authelet M., Dedecker R., Chanut A., Lacor P., Lavaur J., Sazdovitch V., et al. Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer's brains. Acta Neuropathol. 2013, 125:861-878.
4. Barral S., Reitz C., Small S.A., Mayeux R. Genetic variants in a CREB-dependent histone acetylation pathway influence memory performance in cognitively healthy elderly. Neurobiol. Aging 2014, Published online June 28, 2014. 10.1016/j.neurobiolaging.2014.06.024.
5. Benes F.M., Berretta S. GABAergic interneurons: implications forunderstanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001, 25:1-27.
6. Bhalla A., Vetanovetz C.P., Morel E., Chamoun Z., Di Paolo G., Small S.A. The location and trafficking routes of the neuronal retromer and its role in amyloid precursor protein transport. Neurobiol. Dis. 2012, 47:126-134.
7. Braak H., Alafuzoff I., Arzberger T., Kretzschmar H., Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006, 112:389-404.
8. Burd C., Cullen P.J. Retromer: a master conductor of endosome sorting. Cold Spring Harb. Perspect. Biol. 2014, 6. pii: a016774.
9. Cataldo A.M., Barnett J.L., Pieroni C., Nixon R.A. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J.Neurosci. 1997, 17:6142-6151.
10. Cataldo A.M., Peterhoff C.M., Troncoso J.C., Gomez-Isla T., Hyman B.T., Nixon R.A. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am. J. Pathol. 2000, 157:277-286.
11. Chapuis J., Hansmannel F., Gistelinck M., Mounier A., Van Cauwenberghe C., Kolen K.V., Geller F., Sottejeau Y., Harold D., Dourlen P., et al. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol. Psychiatry 2013, 18:1225-1234. GERAD Consortium.
12. Davachi L., Wagner A.D. Hippocampal contributions to episodic encoding: insights from relational and item-based learning. J.Neurophysiol. 2002, 88:982-990.
13. Erecińska M., Silver I.A. Metabolism and role of glutamate in mammalian brain. Prog. Neurobiol. 1990, 35:245-296.
14. Fjorback A.W., Seaman M., Gustafsen C., Mehmedbasic A., Gokool S., Wu C., Militz D., Schmidt V., Madsen P., Nyengaard J.R., et al. Retromer binds the FANSHY sorting motif in SorLA to regulate amyloid precursor protein sorting and processing. J.Neurosci. 2012, 32:1467-1480.
15. Friston K.J., Liddle P.F., Frith C.D., Hirsch S.R., Frackowiak R.S. The left medial temporal region and schizophrenia. A PET study. Brain 1992, 115:367-382.
16. Gabrieli J.D.E., Brewer J.B., Desmond J.E., Glover G.H. Separate neural bases of two fundamental memory processes in the human medial temporal lobe. Science 1997, 276:264-266.
17. Gaisler-Salomon I., Miller G.M., Chuhma N., Lee S., Zhang H., Ghoddoussi F., Lewandowski N., Fairhurst S., Wang Y., Conjard-Duplany A., et al. Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia. Neuropsychopharmacology 2009, 34:2305-2322.
18. Gómez-Isla T., Price J.L., McKeel D.W., Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J.Neurosci. 1996, 16:4491-4500.
19. Gracian E.I., Shelley L.E., Morris A.M., Gilbert P.E. Age-related changes in place learning for adjacent and separate locations. Neurobiol. Aging 2013, 34:2304-2309.
20. Heckers S., Rauch S.L., Goff D., Savage C.R., Schacter D.L., Fischman A.J., Alpert N.M. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat. Neurosci. 1998, 1:318-323.
21. Holden H.M., Hoebel C., Loftis K., Gilbert P.E. Spatial pattern separation in cognitively normal young and older adults. Hippocampus 2012, 22:1826-1832.
22. Huijbers W., Mormino E.C., Wigman S.E., Ward A.M., Vannini P., McLaren D.G., Becker J.A., Schultz A.P., Hedden T., Johnson K.A., Sperling R.A. Amyloid deposition is linked to aberrant entorhinal activity among cognitively normal older adults. J.Neurosci. 2014, 34:5200-5210.
23. Israel M.A., Yuan S.H., Bardy C., Reyna S.M., Mu Y., Herrera C., Hefferan M.P., Van Gorp S., Nazor K.L., Boscolo F.S., et al. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 2012, 482:216-220.
24. Jia P., Wang L., Meltzer H.Y., Zhao Z. Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data. Schizophr. Res. 2010, 122:38-42.
25. Kawasaki Y., Suzuki M., Maeda Y., Urata K., Yamaguchi N., Matsuda H., Hisada K., Suzuki M., Takashima T. Regional cerebral blood flow in patients with schizophrenia. A preliminary report. Eur. Arch. Psychiatry Clin. Neurosci. 1992, 241:195-200.
26. Khan U.A., Liu L., Provenzano F.A., Berman D.E., Profaci C.P., Sloan R., Mayeux R., Duff K.E., Small S.A. Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease. Nat. Neurosci. 2014, 17:304-311.
27. Kirwan C.B., Jones C.K., Miller M.I., Stark C.E. High-resolution fMRI investigation of the medial temporal lobe. Hum. Brain Mapp. 2007, 28:959-966.
28. Kraguljac N.V., White D.M., Reid M.A., Lahti A.C. Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia. JAMA Psychiatry 2013, 70:1294-1302.
29. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers M.B., Charney D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 1994, 51:199-214.
30. Lambert J.C., Ibrahim-Verbaas C.A., Harold D., Naj A.C., Sims R., Bellenguez C., DeStafano A.L., Bis J.C., Beecham G.W., Grenier-Boley B., et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat. Genet. 2013, 45:1452-1458. European Alzheimer's Disease Initiative (EADI), Genetic and Environmental Risk in Alzheimer's DiseaseGenetic and Environmental Risk in Alzheimer's Disease, Alzheimer's Disease Genetic ConsortiumAlzheimer's Disease Genetic Consortium, Cohorts for Heart and Aging Research in Genomic EpidemiologyCohorts for Heart and Aging Research in Genomic Epidemiology.
31. Lucin K.M., O'Brien C.E., Bieri G., Czirr E., Mosher K.I., Abbey R.J., Mastroeni D.F., Rogers J., Spencer B., Masliah E., Wyss-Coray T. Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer's disease. Neuron 2013, 79:873-886.
32. Lue L.F., Kuo Y.M., Roher A.E., Brachova L., Shen Y., Sue L., Beach T., Kurth J.H., Rydel R.E., Rogers J. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 1999, 155:853-862.
33. Maciejewski P.K., Rothman D.L. Proposed cycles for functional glutamate trafficking in synaptic neurotransmission. Neurochem. Int. 2008, 52:809-825.
34. Malaspina D., Harkavy-Friedman J., Corcoran C., Mujica-Parodi L., Printz D., Gorman J.M., Van Heertum R. Resting neural activity distinguishes subgroups of schizophrenia patients. Biol. Psychiatry 2004, 56:931-937.
35. Matrisciano F., Tueting P., Maccari S., Nicoletti F., Guidotti A. Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice. Neuropsychopharmacology 2012, 37:929-938.
36. Mecozzi V.J., Berman D.E., Simoes S., Vetanovetz C., Awal M.R., Patel V.M., Schneider R.T., Petsko G.A., Ringe D., Small S.A. Pharmacological chaperones stabilize retromer to limit APP processing. Nat. Chem. Biol. 2014, 10:443-449.
37. Medoff D.R., Holcomb H.H., Lahti A.C., Tamminga C.A. Probing the human hippocampus using rCBF: contrasts in schizophrenia. Hippocampus 2001, 11:543-550.
38. Michel C.H., Kumar S., Pinotsi D., Tunnacliffe A., St George-Hyslop P., Mandelkow E., Mandelkow E.M., Kaminski C.F., Kaminski Schierle G.S. Extracellular monomeric tau protein is sufficient to initiate the spread of tau protein pathology. J.Biol. Chem. 2014, 289:956-967.
39. Miller M.I., Younes L., Ratnanather J.T., Brown T., Trinh H., Postell E., Lee D.S., Wang M.C., Mori S., O'Brien R., Albert M. The diffeomorphometry of temporal lobe structures in preclinical Alzheimer's disease. Neuroimage Clin. 2013, 3:352-360. BIOCARD Research Team.
40. Moghaddam B., Adams B., Verma A., Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J.Neurosci. 1997, 17:2921-2927.
41. Morel E., Chamoun Z., Lasiecka Z.M., Chan R.B., Williamson R.L., Vetanovetz C., Dall'Armi C., Simoes S., Point Du Jour K.S., McCabe B.D., et al. Phosphatidylinositol-3-phosphate regulates sorting and processing of amyloid precursor protein through the endosomal system. Nat. Commun. 2013, 4:2250.
42. Moreno H., Wu W.E., Lee T., Brickman A., Mayeux R., Brown T.R., Small S.A. Imaging the Abeta-related neurotoxicity of Alzheimer disease. Arch. Neurol. 2007, 64:1467-1477.
43. Morgagni G.B. De Sedibus, et Causis Morborum per Anatomen Indagatis Libri Quinque [On the Seats and Causes and Disease through an Investigation of Anatomy] 1761, Typographia Remondini, Venice, Italy.
44. Muhammad A., Flores I., Zhang H., Yu R., Staniszewski A., Planel E., Herman M., Ho L., Kreber R., Honig L.S., et al. Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Abeta accumulation. Proc. Natl. Acad. Sci. USA 2008, 105:7327-7332.
45. Muratore C.R., Rice H.C., Srikanth P., Callahan D.G., Shin T., Benjamin L.N., Walsh D.M., Selkoe D.J., Young-Pearse T.L. The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons. Hum. Mol. Genet. 2014, 23:3523-3536.
46. Näslund J., Haroutunian V., Mohs R., Davis K.L., Davies P., Greengard P., Buxbaum J.D. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 2000, 283:1571-1577.
47. Pavlopoulos E., Jones S., Kosmidis S., Close M., Kim C., Kovalerchik O., Small S.A., Kandel E.R. Molecular mechanism for age-related memory loss: the histone-binding protein RbAp48. Sci. Transl. Med. 2013, 5:ra115.
48. Pereira A.C., Huddleston D.E., Brickman A.M., Sosunov A.A., Hen R., McKhann G.M., Sloan R., Gage F.H., Brown T.R., Small S.A. An invivo correlate of exercise-induced neurogenesis in the adult dentate gyrus. Proc. Natl. Acad. Sci. USA 2007, 104:5638-5643.
49. Ramón y Cajal S. Histologie du Systeme Nerveux de l'Homme et des Vertebretes, Volumes 1 and 2 [Histology of the Nervous System of Man and Vertebrates, Volumes 1 and 2] 1911, A. Maloine, Paris.
50. Reitz C., Tosto G., Vardarajan B., Rogaeva E., Ghani M., Rogers R.S., Conrad C., Haines J.L., Pericak-Vance M.A., Fallin M.D., et al. Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP). Transl. Psychiatr. 2013, 3:e256. Alzheimer's Disease Genetics Consortium (ADGC).
51. Rogaeva E., Meng Y., Lee J.H., Gu Y., Kawarai T., Zou F., Katayama T., Baldwin C.T., Cheng R., Hasegawa H., et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat. Genet. 2007, 39:168-177.
52. Schobel S.A., Lewandowski N.M., Corcoran C.M., Moore H., Brown T., Malaspina D., Small S.A. Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Arch. Gen. Psychiatry 2009, 66:938-946.
53. Schobel S.A., Chaudhury N.H., Khan U.A., Paniagua B., Styner M.A., Asllani I., Inbar B.P., Corcoran C.M., Lieberman J.A., Moore H., Small S.A. Imaging patients with psychosis and a mouse model establishes aspreading pattern of hippocampal dysfunction and implicates glutamate as a driver. Neuron 2013, 78:81-93.
54. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298:789-791.
55. Small S.A. Age-related memory decline: current concepts and future directions. Arch. Neurol. 2001, 58:360-364.
56. Small S.A., Gandy S. Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis. Neuron 2006, 52:15-31.
57. Small S.A., Perera G.M., DeLaPaz R., Mayeux R., Stern Y. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. Ann. Neurol. 1999, 45:466-472.
58. Small S.A., Wu E.X., Bartsch D., Perera G.M., Lacefield C.O., DeLaPaz R., Mayeux R., Stern Y., Kandel E.R. Imaging physiologic dysfunction of individual hippocampal subregions in humans and genetically modified mice. Neuron 2000, 28:653-664.
59. Small S.A., Tsai W.Y., DeLaPaz R., Mayeux R., Stern Y. Imaging hippocampal function across the human life span: is memory decline normal or not?. Ann. Neurol. 2002, 51:290-295.
60. Small S.A., Chawla M.K., Buonocore M., Rapp P.R., Barnes C.A. Imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging. Proc. Natl. Acad. Sci. USA 2004, 101:7181-7186.
61. Small S.A., Kent K., Pierce A., Leung C., Kang M.S., Okada H., Honig L., Vonsattel J.P., Kim T.W. Model-guided microarray implicates the retromer complex in Alzheimer's disease. Ann. Neurol. 2005, 58:909-919.
62. Small S.A., Schobel S.A., Buxton R.B., Witter M.P., Barnes C.A. A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat. Rev. Neurosci. 2011, 12:585-601.
63. van Praag H., Lucero M.J., Yeo G.W., Stecker K., Heivand N., Zhao C., Yip E., Afanador M., Schroeter H., Hammerstone J., Gage F.H. Plant-derived flavanol (-)epicatechin enhances angiogenesis and retention of spatial memory in mice. J.Neurosci. 2007, 27:5869-5878.
64. Vardarajan B.N., Bruesegem S.Y., Harbour M.E., Inzelberg R., Friedland R., St.George-Hyslop P., Seaman M.N., Farrer L.A. Identification of Alzheimer disease-associated variants in genes that regulate retromer function. Neurobiol. Aging 2012, 33:2231.e15-2231.e30.
65. Villeda S.A., Plambeck K.E., Middeldorp J., Castellano J.M., Mosher K.I., Luo J., Smith L.K., Bieri G., Lin K., Berdnik D., et al. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat. Med. 2014, 20:659-663.
66. Virchow R.L.K. Cellular Pathology as Based upon Physiological andPathological Histology 1863, Dover Publications, New York, Republished in 1971.
67. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., Nord A.S., Kusenda M., Malhotra D., Bhandari A., et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320:539-543.
68. Wen L., Tang F.L., Hong Y., Luo S.W., Wang C.L., He W., Shen C., Jung J.U., Xiong F., Lee D.H., et al. VPS35 haploinsufficiency increases Alzheimer's disease neuropathology. J.Cell Biol. 2011, 195:765-779.
69. West M.J. Regionally specific loss of neurons in the aging human hippocampus. Neurobiol. Aging 1993, 14:287-293.
70. West M.J., Coleman P.D., Flood D.G., Troncoso J.C. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 1994, 344:769-772.
71. Whitwell J.L., Przybelski S.A., Weigand S.D., Knopman D.S., Boeve B.F., Petersen R.C., Jack C.R. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain 2007, 130:1777-1786.
72. Whitwell J.L., Shiung M.M., Przybelski S.A., Weigand S.D., Knopman D.S., Boeve B.F., Petersen R.C., Jack C.R. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology 2008, 70:512-520.
73. Wilson G.M., Flibotte S., Chopra V., Melnyk B.L., Honer W.G., Holt R.A. DNA copy-number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in glutamate signaling. Hum. Mol. Genet. 2006, 15:743-749.
74. Winchester C.L., Pratt J.A., Morris B.J. Risk genes for schizophrenia: translational opportunities for drug discovery. Pharmacol. Ther. 2014, 143:34-50.
75. Wisse L.E., Biessels G.J., Heringa S.M., Kuijf H.J., Koek D.H., Luijten P.R., Geerlings M.I. Hippocampal subfield volumes at 7T in early Alzheimer's disease and normal aging. Neurobiol. Aging 2014, 35:2039-2045. Utrecht Vascular Cognitive Impairment (VCI) Study Group.
76. Wu W., Brickman A.M., Luchsinger J., Ferrazzano P., Pichiule P., Yoshita M., Brown T., DeCarli C., Barnes C.A., Mayeux R., et al. The brain in the age of old: the hippocampal formation is targeted differentially by diseases of late life. Ann. Neurol. 2008, 64:698-706.
77. Yassa M.A., Stark C.E. Pattern separation in the hippocampus. Trends Neurosci. 2011, 34:515-525.
78. Yassa M.A., Lacy J.W., Stark S.M., Albert M.S., Gallagher M., Stark C.E. Pattern separation deficits associated with increased hippocampal CA3 and dentate gyrus activity in nondemented older adults. Hippocampus 2011, 21:968-979.
79. Yassa M.A., Mattfeld A.T., Stark S.M., Stark C.E. Age-related memory deficits linked to circuit-specific disruptions in the hippocampus. Proc. Natl. Acad. Sci. USA 2011, 108:8873-8878.
80. Ye S., Huang Y., Müllendorff K., Dong L., Giedt G., Meng E.C., Cohen F.E., Kuntz I.D., Weisgraber K.H., Mahley R.W. Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target. Proc. Natl. Acad. Sci. USA 2005, 102:18700-18705.
81. Yu J.T., Tan L., Hardy J. Apolipoprotein E in Alzheimer's disease: an update. Annu. Rev. Neurosci. 2014, 37:79-100.
82. Zeineh M.M., Engel S.A., Bookheimer S.Y. Application of cortical unfolding techniques to functional MRI of the human hippocampal region. Neuroimage 2000, 11:668-683.
83. Zhang Q., Vo N., Goodman R.H. Histone binding protein RbAp48 interacts with a complex of CREB binding protein and phosphorylated CREB. Mol. Cell. Biol. 2000, 20:4970-4978.